eHealth (NASDAQ: EHTH) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued to investors on Tuesday, AnalystRatings.Net reports. They currently have a $27.10 target price on the stock. Zacks‘ target price would indicate a potential upside of 11.61% from the company’s current price.
EHTH has been the subject of a number of other recent research reports. Analysts at Lazard Capital Markets downgraded shares of eHealth from a “buy” rating to a “neutral” rating in a research note to investors on Tuesday, May 21st. Finally, analysts at Janney Montgomery Scott upgraded shares of eHealth from a “neutral” rating to a “buy” rating in a research note to investors on Tuesday, April 2nd. They now have a $27.00 price target on the stock.
Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. eHealth currently has an average rating of “Buy” and a consensus target price of $26.02.
eHealth (NASDAQ: EHTH) traded up 0.82% on Tuesday, hitting $24.46. eHealth has a 52-week low of $14.34 and a 52-week high of $28.17. The stock’s 50-day moving average is currently $18.8. The company has a market cap of $476.2 million and a price-to-earnings ratio of 69.12.
eHealth (NASDAQ: EHTH) last announced its earnings results on Thursday, April 25th. The company reported $0.17 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.15 by $0.02. The company had revenue of $43.21 million for the quarter, compared to the consensus estimate of $41.48 million. During the same quarter in the previous year, the company posted $0.17 earnings per share. The company’s revenue for the quarter was up 16.5% on a year-over-year basis. eHealth has set its FY13 guidance at $0.61-0.71 EPS. On average, analysts predict that eHealth will post $0.42 earnings per share for the current fiscal year.
eHealth, Inc. (NASDAQ: EHTH) is an online source of health insurance for individuals, families and small businesses.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.